SCOPUS 정보 검색 플랫폼

Volumn 60, Issue 1, 2001, Pages 60-65

Docetaxel in patients with anthracycline-resistant advanced breast cancer

(11) Vici, Patrizia a Belli, Franca a Di Lauro, Luigi a Amodio, Antonella a Conti, Francesca a Foggi, Paolo a Gionfra, Tommaso a Morelli, Maria Francesca a Botti, Claudio a Ferraironi, Alessandro a Lopez, Massimo a

a REGINA ELENA NATIONAL CANCER INSTITUTE (Italy)

Author keywords

Anthracycline resistance; Breast cancer; Docetaxel

Indexed keywords

ANTHRACYCLINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ADULT; AGED; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DIARRHEA; DISEASE CLASSIFICATION; DOSE TIME EFFECT RELATION; DRUG RESPONSE; EDEMA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TOXICITY; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEUTROPENIA; PACLITAXEL; SURVIVAL ANALYSIS; TAXOIDS; TREATMENT OUTCOME;

EID: 17744396665 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000055298 Document Type: Article

Times cited : (17)

References (20)

1
- 0027471578
- Chemotherapy and survival in advanced breast cancer: The inclusion of doxorubicin in Cooper type regimens
- (1993) Br J Cancer , vol.67 , pp. 801-805
- A'Hern, R.P.¹ Smith, I.E.² Ebbs, S.R.³

2
- 0000582426
- Treatment of metastatic breast cancer
- Harris JR, Lippman ME, Morrow M, Osborne CK (eds): Diseases of the Breast, ed 2. Philadelphia, Lippincott
- (2000) , pp. 749-797
- Ellis, M.J.¹ Hayes, D.F.² Lippman, M.E.³

3
- 0028827482
- Phase II trial of docetaxel: A new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 2886-2884
- Valero, V.¹ Holmes, F.A.² Walters, R.S.³ Theriault, R.L.⁴ Esparza, L.⁵ Fraschini, G.⁶ Fonseca, G.A.⁷ Bellet, R.E.⁸ Buzdar, A.U.⁹ Hortobagyi, G.N.¹⁰

4
- 0028824166
- Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 2879-2885
- Ravdin, P.M.¹ Burris III, H.A.² Cook, G.³ Eisenberg, P.⁴ Kane, M.⁵ Bierman, W.A.⁶ Mortimer, J.⁷ Genovois, E.⁸ Bellet, R.E.⁹

5
- 0001213908
- A phase II trial of docetaxel in patients with anthracycline-resistant metastatic breast cancer
- (1995) Eur J Cancer , vol.31 A , Issue.SUPPL. 5 , pp. 575-576
- Guastalla, J.¹ Bonneterre, J.² Fumoleau, P.³ Piccart, M.⁴ Tubiana, M.⁵ Chevallier, B.⁶ Nieamann, C.⁷ Alakl, N.⁸ Nichol, A.⁹ Riva, A.¹⁰ Marty, M.¹¹

6
- 4244044144
- Docetaxel for patients with previously treated metastatic breast cancer
- (1999) Proc Am Soc Clin Oncol , vol.18
- Da Luz, R.¹ Cortes, P.² Ribeiro, M.³ Miranda, M.P.⁴ Quintella, A.⁵ Costa, L.⁶ Costa, E.B.⁷

7
- 4244086399
- Quality of life audit during metastatic breast cancer chemotherapy: Analysis of 161 patients treated with docetaxel
- (1999) Proc Am Soc Clin Oncol , vol.18
- Eggleton, S.P.H.¹ Twelves, C.J.² Miles, D.W.³ Burrell, A.⁴ Hall, A.⁵

8
- 17744371857
- Docetaxel in advanced or metastatic breast cancer (MBC). A phase II South America experience
- (1999) Proc Am Soc Clin Oncol , vol.18
- Orlandi-Jorquera, L.¹ Ruiz, C.² Cabral Filho, S.³ Alberto, M.⁴ Palacios, L.E.⁵ Garbino, C.⁶ Vargas Baez, C.A.⁷ Moncayo, J.⁸ Orlandi-Jorquera, F.⁹ Bronfman, L.¹⁰ Ballesteros, G.¹¹

9
- 0032991996
- Docetaxel in the community setting: An analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK. UK Study Group
- (1999) Ann Oncol , vol.10 , pp. 205-210
- O'Brien, M.E.R.¹ Leonard, R.C.² Barrett-Lee, P.J.³ Eggleton, S.P.H.⁴ Bizzari, J.P.⁵

10
- 0032949449
- Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group
- (1999) J Clin Oncol , vol.17 , pp. 1413-1424
- Nabholtz, J.M.¹ Senn, H.J.² Bezwoda, W.R.³ Melnychuk, D.⁴ Deschenes, L.⁵ Douma, J.⁶ Vandenberg, T.A.⁷ Rapoport, B.⁸ Rosso, R.⁹ Trillet-Lenoir, V.¹⁰ Drbal, J.¹¹ Molino, A.¹² Nortier, J.W.R.¹³ Richel, J.R.¹⁴ Nagykalnai, T.¹⁵ Siedlecki, P.¹⁶ Wilking, N.¹⁷ Genot, J.Y.¹⁸ Hupperets, P.S.¹⁹ Pannuti, F.²⁰ more..

11
- 17344390083
- Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: A randomised phase III study with crossover on progression by the Scandinavian Breast Group
- (1999) Eur J Cancer , vol.35 , pp. 1194-1201
- Sjöström, J.¹ Blomqvist, C.² Mouridsen, H.³ Pluzanska, A.⁴ Ottosson-Lönn, S.⁵ Bengtsson, N.O.⁶ Ostenstad, B.⁷ Mjaaland, I.⁸ Palm-Sjövall, M.⁹ Wist, E.¹⁰ Valvere, V.¹¹ Anderson, H.¹² Bergh, J.¹³

12
- 0000812868
- Taxotere versus 5-fluorouracil + Navelbine in patients with metastatic breast cancer as 2nd line chemotherapy: A phase III study
- (1998) Breast Cancer Res Treat , vol.50 , pp. 261
- Bonneterre, J.¹ Monnier, A.² Roche, J.³ Fargeot, P.⁴ Namer, M.⁵ Guastalla, J.P.⁶ Rios, M.⁷ Serini, P.⁸ Culine, S.⁹ Jubaxana, M.¹⁰ Eymard, J.C.¹¹ Assadouriam, S.¹²

13
- 4244044147
- 2 docetaxel in patients with metastatic breast cancer according to definition of doxorubicin resistance
- (1999) Proc Am Soc Clin Oncol , vol.18
- Ando, M.¹ Watanabe, T.² Nagata, K.³ Katsumata, N.⁴ Narabayashi, M.⁵ Adachi, I.⁶

14
- 0029085064
- Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer
- (1995) Semin Oncol , vol.22 , Issue.SUPPL. 18 , pp. 33-39
- Dieras, V.¹ Marty, M.² Tubiana, N.³ Corette, L.⁴ Morvan, F.⁵ Serin, D.⁶ Mignot, L.⁷ Chazard, M.⁸ Garet, F.⁹ Onetto, N.¹⁰

15
- 0033956932
- Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: A European Organization for Research and Treatment of Cancer randomized study with crossover
- (2000) J Clin Oncol , vol.18 , pp. 724-733
- Paridaens, R.¹ Biganzoli, L.² Bruning, P.³ Klijn, J.G.M.⁴ Gamucci, T.⁵ Houston, S.⁶ Coleman, R.⁷ Schachter, J.⁸ Van Vreckem, A.⁹ Sylvester, R.¹⁰ Awada, A.¹¹ Wildiers, J.¹² Piccart, M.¹³

16
- 0002088796
- Phase II trial of doxorubicin vs paclitaxel vs doxorubicin + paclitaxel as first-line therapy for metastatic breast cancer: An Intergroup trial
- (1997) Proc Am Soc Clin Oncol , vol.16
- Sledge G.W., Jr.¹ Neuberg, D.² Ingle, J.³ Martino, S.⁴ Wood, W.⁵

17
- 0021991378
- A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma
- (1985) Cancer , vol.55 , pp. 337-340
- Yau, J.C.¹ Yap, Y.Y.² Budzar, A.U.³ Hortobagyi, G.N.⁴ Bodey, G.P.⁵ Blumenschein, G.R.⁶

18
- 0031002744
- Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer
- (1997) J Clin Oncol , vol.15 , pp. 1395-1400
- Livingston, R.B.¹ Ellis, G.K.² Gralow, J.R.³ Williams, M.A.⁴ White, R.⁵ McGuirt, C.⁶ Adamkiewicz, B.B.⁷ Long, C.A.⁸

19
- 0033402622
- Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer
- (1999) Ann Oncol , vol.10 , pp. 1457-1460
- Spielmann, M.¹ Llombart, A.² Zelek, L.³ Sverdin, R.⁴ Rixe, O.⁵ Le Cesne, A.⁶

20
- 0030026360
- Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer
- (1996) Oncology , vol.53 , pp. 16-18
- Vici, P.¹ Di Lauro, L.² Carpano, S.³ Amodio, A.⁴ Pignatti, F.⁵ Casali, A.⁶ Conti, F.⁷ Lopez, M.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.